The consortium that is behind the project consists of public health institutes, universities, small and medium-sized enterprises, vaccine companies and patient organizations from various European countries (Spain, France, Great Britain, Belgium, Holland, Finland), in addition to Italy, which participates with the University of Florence (UNIFI) and the Istituto Superiore di Sanità (National Institute of Health).
Born in 2017, the project receives funding from the EU Horizon 2020 program and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The research will have a duration of 5 years and is coordinated by FISABIO, a foundation for the promotion of health and biomedical research in Valencia, Spain.